Puma Biotechnology - Crunchbase Company Profile & Funding
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | Fox Business
Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib, an Investigational Aurora Kinase A Inhibitor | Business Wire
What Happened To Puma Biotechnology?
Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib, an Investigational Aurora Kinase A Inhibitor | Business Wire
Is Puma Biotechnology a Buy? | The Motley Fool
Puma Biotechnology falls more than 20%
Former Puma Biotech Executive Gets U.S. Prison Term for Insider Trading